Yahoo Finance report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Why SNDL Stock dropped -4.61% Today — RQD Quant Desk Flash
SNDL Inc. (SNDL) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, SNDL Inc. (NASDAQ: SNDL) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.24 (-4.61% 1D, market cap $316.3M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, SNDL ranks #325 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SNDL compare to CGC and OBIO in the Health Care sector?
▼
Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $285.6M) and OBIO (Orchestra BioMed Holdings Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $366.0M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SNDL?
▼
For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #325 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
SEC XBRL Trailing 12 Months: 0.2% FCF Margin ($8.9M FCF) & 52% Gross Margin
Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)
⚔️ Adversarial Opposing Case: What Could Spark a SNDL Turnaround Squeeze
While SNDL currently carries a cautious 48/100 (D) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.32) and Max Pain ($1.30) forces dealer call-delta covering toward $2.46.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why SNDL Stock dropped -4.61% Today — RQD Quant Desk Flash
SNDL Inc. (SNDL) dropped -4.61% to $1.24, trading at 9% of its 52-week range ($1.13 – $2.34). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 9% of its 52-week range ($1.13 – $2.34) with RSI-14 at 53.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.3% around $1.24 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $8.9M annual free cash flow.
Seeking Alpha report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance UK report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
The Globe and Mail report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Mugglehead Investment Magazine report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
marketscreener.com report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
SNDL's Q3 sales beat expectations, but margin pressure and persistent cannabis weakness cloud its recovery. Can buybacks and U.S. expansion turn the tide?
SNDL Inc. posted record free cash flow but faces near-term earnings pressure from restructuring and product cuts. Click for this earnings update of SNDL stock.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNDL)
- ✓Walkthrough of SNDL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
SNDL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SNDL today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SNDL. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNDL)
1. Head-to-Head Health Care Peer Comparison (SNDL vs. CGC, OBIO, USNA, TLRY)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, SNDL Inc. (SNDL) ranks #325 by composite RQD confidence (48/100, grade D) and #515 by equity capitalization ($316.3M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. USNA currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with SNDL at 48/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SNDL
ACTIVE
SNDL Inc. | D | 48/100 | — | — | — | -4.61% | $316.3M | Benchmark Subject |
| CGC Canopy Growth Corporation | D- | 41/100 | — | — | — | -3.33% | $285.6M | /cgc-vs-sndl → |
| OBIO Orchestra BioMed Holdings Inc. | D- | 36/100 | — | 96.0% | -35.0% | -2.96% | $366.0M | /obio-vs-sndl → |
| USNA USANA Health Sciences Inc. | D | 50/100 | 24.6x | 78.3% | 7.9% | -0.21% | $265.0M | /usna-vs-sndl → |
| TLRY Tilray Brands Inc. | E | 20/100 | — | 28.4% | -3.9% | -4.17% | $390.2M | /tlry-vs-sndl → |
2. SNDL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTSNDL Inc. (SNDL) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $316.3M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. SNDL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, SNDL Inc. (NASDAQ: SNDL) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.24 (-4.61% 1D, market cap $316.3M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, SNDL ranks #325 in composite RQD confidence.
How does SNDL compare to CGC and OBIO in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $285.6M) and OBIO (Orchestra BioMed Holdings Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $366.0M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SNDL?
For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #325 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SNDL trading relative to its 50-day, 200-day, and 52-week technical levels?
SNDL last traded at $1.24 (-4.61% on volume of 1,385,411 shares), positioning the stock -6.06% below its 50-day simple moving average ($1.32) and -10.79% below its 200-day simple moving average ($1.39). Across its 52-week range of $1.13 to $2.34, SNDL sits at the 9.1% percentile with a 14-day RSI of 53.4 (NEUTRAL RANGE) and an implied next-earnings move of ±8.3% ($1.14 to $1.34).
SNDL Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SNDL stock moving today?
Why SNDL Stock dropped -4.61% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
SNDL — SNDL Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, SNDL scores 48 out of 100, a letter grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The five pillars are: Fundamental Cash Engine at 12 / 20 (ROIC 0%; FCF yield 0%), Whale 13F Flow at 6 / 20 (institutional accumulation and options positioning), Insider Conviction at 9 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 8 / 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 13 / 20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.5).
For a prospective investor, the weakest pillars are the cash engine and the institutional and insider flow pillars, which together signal that the source data shows no measurable return on invested capital or free cash flow yield, and only limited evidence of institutional or insider conviction. The forensic balance sheet pillar is the strongest relative to the rest, with an Altman Z of 2.5 and a Piotroski F of 6/9, which the rating treats as moderate rather than distressed. Upside drivers would need to come from a change in cash generation, since the rating's valuation context is constrained by the absence of earnings-based multiples in the source data. The 2nd-order implication is that the current price of 1.3 sits within a 52-week range of $1.13 - $2.34, so the stock is trading in the lower portion of its recent band while the rating remains in distribution-warning territory.
Recent Catalysts & News Wire Analysis
- Yahoo Finance (YELLOW, Market Wire) headlined a Q3 earnings cash flow question for SNDL.
- Seeking Alpha (YELLOW, Market Wire) headlined short-term issues following Q3 earnings.
- The Globe and Mail (GREEN, Catalyst) reported record Q3 free cash flow and expanded capital returns after shareholders rejected a consolidation.
- Stock Titan (GREEN, Catalyst) noted a possible buyback that would cap the price 17.4% above the October 14 close.
- Mugglehead Investment Magazine (YELLOW, Market Wire) reported that director Carlo Cannell resigned without a named successor.
- Butterfly Supply-Chain Graph: supply_chain is NONE, with no butterfly links and no proprietary signals.
The tension in the news flow is between a GREEN record-free-cash-flow catalyst and a YELLOW earnings question, alongside a board resignation. The rating's 0% FCF yield sits uneasily beside the reported record free cash flow, and the source data does not reconcile the two.
Open Questions
- What are the reported revenue, operating income, net income, and free cash flow figures for recent periods, given that the financials section is empty?
- Why does the RQD rating show 0% ROIC and 0% FCF yield while news reports record Q3 free cash flow?
- What are the P/E, forward P/E, and EV/EBITDA multiples, given that they are not available in source data?
- Who are the institutional and insider holders, and what is the direction of their recent activity?
- What is the status of the proposed buyback and the director resignation, and who may succeed the director?
SNDL Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for SNDL Inc. (SNDL) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance UK report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
The Globe and Mail report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
Mugglehead Investment Magazine report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
marketscreener.com report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.
SNDL Bull vs. Bear Conversation Board — What's Your Call at $1.24?
🔥 Official Bull vs. Bear Debate: Is SNDL (D • RQD 48/100) a Buy at $1.30?
Welcome to the SNDL (SNDL Inc.) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Medicinal Chemicals and Botanical Products. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on SNDL — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on SNDL, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless SNDL Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
SNDL cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on SNDL, the market is fixating on short-term headline noise in Medicinal Chemicals and Botanical Products and ignoring the balance sheet and cash flow trajectory. At $1.30 (52-wk range $1.13 - $2.34), any beat on forward guidance forces shorts and underweight funds to chase.